The pro-fibrotic transforming growth factor (TGF)-β, which is upregulated in CKD, is another mediator of reduced renal klotho in CKD, facilitating adverse Wnt/beta-catenin activation in the kidney [110]. The gene discussed is CTNNB1; the disease is chronic kidney disease.